188 related articles for article (PubMed ID: 21048493)
1. New advances in targeted therapies for squamous cell carcinoma of the head and neck.
Machiels JP; Schmitz S
Anticancer Drugs; 2011 Aug; 22(7):626-33. PubMed ID: 21048493
[TBL] [Abstract][Full Text] [Related]
2. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
Le Tourneau C; Siu LL
Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
[TBL] [Abstract][Full Text] [Related]
3. Molecular-targeted therapies in head and neck cancer.
Rao SD; Fury MG; Pfister DG
Semin Radiat Oncol; 2012 Jul; 22(3):207-13. PubMed ID: 22687945
[TBL] [Abstract][Full Text] [Related]
4. Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy.
Machiels JP; Schmitz S
Curr Opin Oncol; 2011 May; 23(3):241-8. PubMed ID: 21358328
[TBL] [Abstract][Full Text] [Related]
5. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Gilbert J; Argiris A
Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted therapies in head and neck cancer.
Ferreira MB; Lima JP; Cohen EE
Expert Opin Investig Drugs; 2012 Mar; 21(3):281-95. PubMed ID: 22239178
[TBL] [Abstract][Full Text] [Related]
8. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
9. Emerging molecular targeted therapies in the treatment of head and neck cancer.
Bozec A; Peyrade F; Fischel JL; Milano G
Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
12. Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.
Simpson DR; Mell LK; Cohen EE
Oral Oncol; 2015 Apr; 51(4):291-8. PubMed ID: 25532816
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents.
Harrington KJ; Kazi R; Bhide SA; Newbold K; Nutting CM
Indian J Cancer; 2010; 47(3):248-59. PubMed ID: 20587899
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in squamous cell carcinoma of the head and neck.
Gold KA; Lee HY; Kim ES
Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).
Price KA; Cohen EE
Oral Oncol; 2015 May; 51(5):399-408. PubMed ID: 25725588
[TBL] [Abstract][Full Text] [Related]
16. Molecular targeted therapy of head and neck cancer: review and clinical development challenges.
Le Tourneau C; Faivre S; Siu LL
Eur J Cancer; 2007 Nov; 43(17):2457-66. PubMed ID: 17904355
[TBL] [Abstract][Full Text] [Related]
17. [Anti-angiogenesis - a therapy concept in the treatment of head and neck carcinomas? A review].
Riedel F; Hörmann K
Laryngorhinootologie; 2001 Sep; 80(9):535-41. PubMed ID: 11555787
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathway.
Lau PC; Chan AT
Anticancer Drugs; 2011 Aug; 22(7):665-73. PubMed ID: 21709616
[TBL] [Abstract][Full Text] [Related]
19. Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.
Campbell NP; Hensing TA; Bhayani MK; Shaikh AY; Brockstein BE
Expert Rev Anticancer Ther; 2016 Aug; 16(8):847-58. PubMed ID: 27400139
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeted therapies in all histologies of head and neck cancers: an update.
Razak AR; Siu LL; Le Tourneau C
Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
